Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network

Robert F. Forman, Dace Svikis, Ivan D. Montoya, Jack Blaine

Research output: Contribution to journalArticle

Abstract

Several instruments for diagnosing substance use disorders (SUD) have been developed, but to date none has emerged as the standard for community-based clinical studies. To select the most suitable SUD diagnostic instrument for its clinical trials, the National Drug Abuse Treatment Clinical Trials Network (CTN) implemented a procedure in which 36 university-based addiction researchers and 62 community-based addiction treatment providers evaluated and ranked five widely recognized diagnostic instruments: (1) the SUD section of the Structured Clinical Interview for DSM-IV (SCID); (2) the SUD section of the Composite International Diagnostic Interview, 2nd ed. (CIDI-2); (3) the SUD section of the Diagnostic Interview Schedule for DSM-IV Diagnosis (DIS-IV); (4) the Diagnostic Statistical Manual-IV Checklist (DSM-IV Checklist); and (5) the Substance Dependence Severity Scale (SDSS). To assist the evaluation and ranking process, key characteristics of each instrument were presented in tabular and narrative formats. Participants ranked each instrument from 1 (most preferred) to 5 (least preferred). The SCID received the best overall mean score (2.24) followed by the CIDI-2 (2.59), DIS (2.94), DSM Checklist (3.40) and the SDSS (3.83). After discussing the pragmatic and scientific advantages and disadvantages of each instrument, the CTN Steering Committee selected the CIDI-2. The selection of the CIDI-2 standardizes the collection of diagnostic data and provides a common diagnostic tool for practitioners and clinical researchers in the CTN. Implications for practice/research collaboration and initiatives are explored.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalJournal of Substance Abuse Treatment
Volume27
Issue number1
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Substance-Related Disorders
Clinical Trials
Diagnostic and Statistical Manual of Mental Disorders
Interviews
Checklist
Research Personnel
Appointments and Schedules
Research

Keywords

  • Assessment
  • Clinical trials
  • Diagnosis
  • Substance use disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. / Forman, Robert F.; Svikis, Dace; Montoya, Ivan D.; Blaine, Jack.

In: Journal of Substance Abuse Treatment, Vol. 27, No. 1, 07.2004, p. 1-8.

Research output: Contribution to journalArticle

Forman, Robert F. ; Svikis, Dace ; Montoya, Ivan D. ; Blaine, Jack. / Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. In: Journal of Substance Abuse Treatment. 2004 ; Vol. 27, No. 1. pp. 1-8.
@article{67f81b1910ff4ecdacfaafeca0d599a0,
title = "Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network",
abstract = "Several instruments for diagnosing substance use disorders (SUD) have been developed, but to date none has emerged as the standard for community-based clinical studies. To select the most suitable SUD diagnostic instrument for its clinical trials, the National Drug Abuse Treatment Clinical Trials Network (CTN) implemented a procedure in which 36 university-based addiction researchers and 62 community-based addiction treatment providers evaluated and ranked five widely recognized diagnostic instruments: (1) the SUD section of the Structured Clinical Interview for DSM-IV (SCID); (2) the SUD section of the Composite International Diagnostic Interview, 2nd ed. (CIDI-2); (3) the SUD section of the Diagnostic Interview Schedule for DSM-IV Diagnosis (DIS-IV); (4) the Diagnostic Statistical Manual-IV Checklist (DSM-IV Checklist); and (5) the Substance Dependence Severity Scale (SDSS). To assist the evaluation and ranking process, key characteristics of each instrument were presented in tabular and narrative formats. Participants ranked each instrument from 1 (most preferred) to 5 (least preferred). The SCID received the best overall mean score (2.24) followed by the CIDI-2 (2.59), DIS (2.94), DSM Checklist (3.40) and the SDSS (3.83). After discussing the pragmatic and scientific advantages and disadvantages of each instrument, the CTN Steering Committee selected the CIDI-2. The selection of the CIDI-2 standardizes the collection of diagnostic data and provides a common diagnostic tool for practitioners and clinical researchers in the CTN. Implications for practice/research collaboration and initiatives are explored.",
keywords = "Assessment, Clinical trials, Diagnosis, Substance use disorder",
author = "Forman, {Robert F.} and Dace Svikis and Montoya, {Ivan D.} and Jack Blaine",
year = "2004",
month = "7",
doi = "10.1016/j.jsat.2004.03.012",
language = "English (US)",
volume = "27",
pages = "1--8",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network

AU - Forman, Robert F.

AU - Svikis, Dace

AU - Montoya, Ivan D.

AU - Blaine, Jack

PY - 2004/7

Y1 - 2004/7

N2 - Several instruments for diagnosing substance use disorders (SUD) have been developed, but to date none has emerged as the standard for community-based clinical studies. To select the most suitable SUD diagnostic instrument for its clinical trials, the National Drug Abuse Treatment Clinical Trials Network (CTN) implemented a procedure in which 36 university-based addiction researchers and 62 community-based addiction treatment providers evaluated and ranked five widely recognized diagnostic instruments: (1) the SUD section of the Structured Clinical Interview for DSM-IV (SCID); (2) the SUD section of the Composite International Diagnostic Interview, 2nd ed. (CIDI-2); (3) the SUD section of the Diagnostic Interview Schedule for DSM-IV Diagnosis (DIS-IV); (4) the Diagnostic Statistical Manual-IV Checklist (DSM-IV Checklist); and (5) the Substance Dependence Severity Scale (SDSS). To assist the evaluation and ranking process, key characteristics of each instrument were presented in tabular and narrative formats. Participants ranked each instrument from 1 (most preferred) to 5 (least preferred). The SCID received the best overall mean score (2.24) followed by the CIDI-2 (2.59), DIS (2.94), DSM Checklist (3.40) and the SDSS (3.83). After discussing the pragmatic and scientific advantages and disadvantages of each instrument, the CTN Steering Committee selected the CIDI-2. The selection of the CIDI-2 standardizes the collection of diagnostic data and provides a common diagnostic tool for practitioners and clinical researchers in the CTN. Implications for practice/research collaboration and initiatives are explored.

AB - Several instruments for diagnosing substance use disorders (SUD) have been developed, but to date none has emerged as the standard for community-based clinical studies. To select the most suitable SUD diagnostic instrument for its clinical trials, the National Drug Abuse Treatment Clinical Trials Network (CTN) implemented a procedure in which 36 university-based addiction researchers and 62 community-based addiction treatment providers evaluated and ranked five widely recognized diagnostic instruments: (1) the SUD section of the Structured Clinical Interview for DSM-IV (SCID); (2) the SUD section of the Composite International Diagnostic Interview, 2nd ed. (CIDI-2); (3) the SUD section of the Diagnostic Interview Schedule for DSM-IV Diagnosis (DIS-IV); (4) the Diagnostic Statistical Manual-IV Checklist (DSM-IV Checklist); and (5) the Substance Dependence Severity Scale (SDSS). To assist the evaluation and ranking process, key characteristics of each instrument were presented in tabular and narrative formats. Participants ranked each instrument from 1 (most preferred) to 5 (least preferred). The SCID received the best overall mean score (2.24) followed by the CIDI-2 (2.59), DIS (2.94), DSM Checklist (3.40) and the SDSS (3.83). After discussing the pragmatic and scientific advantages and disadvantages of each instrument, the CTN Steering Committee selected the CIDI-2. The selection of the CIDI-2 standardizes the collection of diagnostic data and provides a common diagnostic tool for practitioners and clinical researchers in the CTN. Implications for practice/research collaboration and initiatives are explored.

KW - Assessment

KW - Clinical trials

KW - Diagnosis

KW - Substance use disorder

UR - http://www.scopus.com/inward/record.url?scp=3042563572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042563572&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2004.03.012

DO - 10.1016/j.jsat.2004.03.012

M3 - Article

C2 - 15223087

AN - SCOPUS:3042563572

VL - 27

SP - 1

EP - 8

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 1

ER -